Yousef Abuhaimed, Alaa Salem Alshamsy, Sarah Albreiki, Khalid Saleh Alkarawi
{"title":"寻常型银屑病的大疱性类天疱疮的发展:1例报告","authors":"Yousef Abuhaimed, Alaa Salem Alshamsy, Sarah Albreiki, Khalid Saleh Alkarawi","doi":"10.19082/7386","DOIUrl":null,"url":null,"abstract":"Introduction: The development of Bullous pemphigoid (BP) in a patient with Psoriasis vulgaris (PV) is rare, as Bullous pemphigoid affects a different age group and its cause is not related to psoriasis. The cause of coexistence between the two diseases is still not clear and requires more reporting and review. Case Presentation: Here, we report a case of a 55-year-old woman with a 22-year history of Psoriasis vulgaris who developed itching and blisters to all four limbs around the scaly plaques of PV. Biopsy of the lesion revealed sub-epidermal bullae and an eosinophilic inflammatory infiltrate. Immunofluorescence microscopy showed linear C3 deposition at the basement membrane zone, and the condition was diagnosed as Bullous pemphigoid. Treatment in such conditions varies among reported cases, and includes methotrexate, cyclosporine, dapsone, azathioprine, and others. In this case, methotrexate was suggested but because patient could not tolerate the course of methotrexate she was started on a combination therapy of cyclosporine 100 mg PO twice daily and tetracycline PO 500 mg PO Q 6 hourly. Both conditions showed significant improvement within 4 weeks. Take-away lesson: As the cause of the concurrence is still unclear, the correct management for such cases still vary. The case report highlighted our experience to benefit dermatologists and physicians, with one therapeutic regimen that can benefit patients who cannot tolerate methotrexate due to its side effects.","PeriodicalId":11603,"journal":{"name":"Electronic Physician","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Development of Bullous Pemphigoid in a Known Case of Psoriasis Vulgaris: a case report\",\"authors\":\"Yousef Abuhaimed, Alaa Salem Alshamsy, Sarah Albreiki, Khalid Saleh Alkarawi\",\"doi\":\"10.19082/7386\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: The development of Bullous pemphigoid (BP) in a patient with Psoriasis vulgaris (PV) is rare, as Bullous pemphigoid affects a different age group and its cause is not related to psoriasis. The cause of coexistence between the two diseases is still not clear and requires more reporting and review. Case Presentation: Here, we report a case of a 55-year-old woman with a 22-year history of Psoriasis vulgaris who developed itching and blisters to all four limbs around the scaly plaques of PV. Biopsy of the lesion revealed sub-epidermal bullae and an eosinophilic inflammatory infiltrate. Immunofluorescence microscopy showed linear C3 deposition at the basement membrane zone, and the condition was diagnosed as Bullous pemphigoid. Treatment in such conditions varies among reported cases, and includes methotrexate, cyclosporine, dapsone, azathioprine, and others. In this case, methotrexate was suggested but because patient could not tolerate the course of methotrexate she was started on a combination therapy of cyclosporine 100 mg PO twice daily and tetracycline PO 500 mg PO Q 6 hourly. Both conditions showed significant improvement within 4 weeks. Take-away lesson: As the cause of the concurrence is still unclear, the correct management for such cases still vary. The case report highlighted our experience to benefit dermatologists and physicians, with one therapeutic regimen that can benefit patients who cannot tolerate methotrexate due to its side effects.\",\"PeriodicalId\":11603,\"journal\":{\"name\":\"Electronic Physician\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Electronic Physician\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19082/7386\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Electronic Physician","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19082/7386","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
引言:寻常型银屑病(PV)患者发生大疱性类天疱疮(BP)是罕见的,因为大疱性天疱疮影响不同年龄组,其病因与银屑病无关。这两种疾病共存的原因尚不清楚,需要更多的报告和审查。病例介绍:我们报告一例55岁女性,有22年寻常型银屑病病史,PV鳞状斑块周围四肢出现瘙痒和水泡。病变活检显示表皮下大疱和嗜酸性炎症浸润。免疫荧光显微镜显示C3在基底膜区呈线性沉积,诊断为大疱性类天疱疮。这种情况下的治疗因报告的病例而异,包括甲氨蝶呤、环孢菌素、氨苯砜、硫唑嘌呤等。在这种情况下,建议使用甲氨蝶呤,但由于患者不能耐受甲氨蝶啶的疗程,她开始接受环孢素100 mg PO每日两次和四环素500 mg PO Q每6小时的联合治疗。两种情况在4周内都有显著改善。吸取教训:由于并发的原因尚不清楚,对此类案件的正确管理仍然各不相同。该病例报告强调了我们的经验,使皮肤科医生和医生受益,其中一种治疗方案可以使因甲氨蝶呤副作用而无法耐受的患者受益。
The Development of Bullous Pemphigoid in a Known Case of Psoriasis Vulgaris: a case report
Introduction: The development of Bullous pemphigoid (BP) in a patient with Psoriasis vulgaris (PV) is rare, as Bullous pemphigoid affects a different age group and its cause is not related to psoriasis. The cause of coexistence between the two diseases is still not clear and requires more reporting and review. Case Presentation: Here, we report a case of a 55-year-old woman with a 22-year history of Psoriasis vulgaris who developed itching and blisters to all four limbs around the scaly plaques of PV. Biopsy of the lesion revealed sub-epidermal bullae and an eosinophilic inflammatory infiltrate. Immunofluorescence microscopy showed linear C3 deposition at the basement membrane zone, and the condition was diagnosed as Bullous pemphigoid. Treatment in such conditions varies among reported cases, and includes methotrexate, cyclosporine, dapsone, azathioprine, and others. In this case, methotrexate was suggested but because patient could not tolerate the course of methotrexate she was started on a combination therapy of cyclosporine 100 mg PO twice daily and tetracycline PO 500 mg PO Q 6 hourly. Both conditions showed significant improvement within 4 weeks. Take-away lesson: As the cause of the concurrence is still unclear, the correct management for such cases still vary. The case report highlighted our experience to benefit dermatologists and physicians, with one therapeutic regimen that can benefit patients who cannot tolerate methotrexate due to its side effects.